首页> 美国卫生研究院文献>Scientific Reports >Water-soluble benzylidene cyclopentanone based photosensitizers for in vitro and in vivo antimicrobial photodynamic therapy
【2h】

Water-soluble benzylidene cyclopentanone based photosensitizers for in vitro and in vivo antimicrobial photodynamic therapy

机译:水溶性亚苄基环戊酮基光敏剂用于体外和体内抗菌光动力疗法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antimicrobial photodynamic therapy (aPDT) has been proposed to cope with the increasing antibiotic resistance among pathogens. As versatile pharmacophores, benzylidene cyclopentanone based photosensitizers (PSs) have been used in various bioactive materials. However, their reports as aPDT agents are very limited, and relationships between their chemical structures and antibacterial abilities have not been systematically discussed. Here, nine water-soluble benzylidene cyclopentanone PSs modified by polyethylene glycol (PEG), carboxylate anionic or pyridyl cationic agents are studied for aPDT. It is found that the binding/uptake abilities and aPDT effects of these PSs toward bacterial cells vary significantly when adjusting the number and position of their terminal charged groups. Though the comparable (also best) binding/uptake amounts are achieved by both cationic PS P3 and anionic PS Y1, only Y1 exhibits much more excellent aPDT activities than other PSs. Antibacterial mechanisms reveal that, relative to the favorable cell wall-binding of cationic PS P3, the anionic PS Y1 can accumulate more in the spheroplast/protoplast of methicillin-resistant Staphylococcus aureus (MRSA), which ensures its high efficient aPDT abilities both in vitro and in vivo. This study suggests the great clinical application potential of Y1 in inactivation of MRSA.
机译:已经提出了抗微生物光动力疗法(aPDT)来应对病原体中日益增加的抗生素抗性。作为多用途药效团,基于亚苄基环戊酮的光敏剂(PSs)已用于各种生物活性材料中。然而,它们作为aPDT制剂的报道非常有限,并且尚未系统地讨论其化学结构与抗菌能力之间的关系。在这里,研究了九种由聚乙二醇(PEG),羧酸盐阴离子或吡啶基阳离子试剂改性的水溶性亚苄基环戊酮PSs的aPDT。发现当调节它们的末端带电基团的数目和位置时,这些PS对细菌细胞的结合/摄取能力和aPDT效应显着变化。尽管阳离子PS P3和阴离子PS Y1都达到了可比的(也是最好的)结合/摄取量,但只有Y1表现出比其他PS更好的aPDT活性。抗菌机制表明,相对于阳离子PS P3的良好细胞壁结合,阴离子PS Y1可以在耐甲氧西林金黄色葡萄球菌(MRSA)的原生质球/原生质中积累更多,从而确保其在体外的高效aPDT能力和体内。这项研究表明Y1在MRSA灭活中具有巨大的临床应用潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号